Related Experiment Video
Updated: Jul 8, 2026
Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
Published on: March 19, 2013
Cell based approaches for myocardial regeneration and artificial myocardium
Jorge Genovese1, Miguel Cortes-Morichetti, Emmanuel Chachques
1University of Pittsburgh Medical Center and McGowan Institute for Regenerative Medicine, PA, USA.
Insights
Stem cell therapy shows promise for regenerating heart muscle damaged by ischemic myocardial disease, offering a potential solution for heart failure. This regenerative approach aims to restore ventricular function and compliance in affected patients.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Biomedical Engineering
Background:
- Ischemic myocardial disease is a leading cause of heart failure, posing significant public health and economic challenges.
- The aging population exacerbates the clinical and financial burden of heart failure.
- Research in heart failure spans multiple disciplines, including cellular biology, tissue engineering, and biophysics.
Purpose of the Study:
- To investigate the potential of stem cell-based regenerative therapy for treating heart failure.
- To explore methods for limiting the consequences of ventricular damage in myocardial infarction and dilated cardiomyopathies.
- To address the challenge of developing bio-artificial myocardium for cardiac repair.
Main Methods:
- Experimental and clinical trials of stem cell-based regenerative therapy.
- Focus on cell types with myogenic and angiogenic potential for myocardial regeneration.
- Development of biological or synthetic matrices for creating bio-artificial myocardium.
Main Results:
- Stem cell therapy demonstrates potential for myocardial regeneration.
- The approach targets restoration of contractile function and compliance in damaged ventricles.
- Various myogenic and angiogenic cell types are being explored for therapeutic efficacy.
Conclusions:
- Stem cell-based regenerative therapy is a promising biological approach for heart failure.
- This therapy offers potential for regenerating damaged heart muscle.
- Creating bio-artificial myocardium using advanced matrices presents a future challenge and opportunity.
Abstract:
Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic problem. Given the aging population, heart failure is becoming an increasing clinical issue and a substantial financial burden. Thus, research in heart failure is of relevant interest and importance, involving specialties such as cellular and molecular biology, tissue engineering, genetics, biophysics and electrophysiology. Stem cell-based regenerative therapy is undergoing experimental and clinical trials in order to limit the consequences of decreased contractile function and compliance of damaged ventricles following myocardial infarction or in patients presenting non-ischemic dilated cardiomyopathies. This biological approach is particularly attractive due to the potential for myocardial regeneration with a variety of myogenic and angiogenic cell types. The development of a bio-artificial myocardium using biological or synthetic matrix is a new challenge.
